ANXA6 and cancer: Previous work3,16,24,25 and data presented here, using genetic and pharmacological NPC1 inhibition or AnxA6 overexpression, demonstrated that blocking LE-Chol export interfered with the migratory, but also invasive behaviour of several cancer cell lines.